Benoît de Ducla is the project manager of the “Cancer Immunotherapy/Cross Indication Launch” Global Medical Team.
He joined Roche in 2005 having worked for Novartis in kidney, hepatic, lung and heart transplant studies preparing Certican and Myfortic launch. Benoît started at Roche as an International Clinical Trial Manager in Pharma Business developing and leading studies in specialty products. In 2009, he moved to Clinical Science Oncology as a Clinical Scientist where he contributed to the MabThera Sub-Cutaneous clinical development program and filing activities. Benoît joined Global Medical Affair Oncology in 2012 as senior International Medical Manager where he was instrumental in developing first non-interventional study in HER2 positive breast cancer and lead the KAMILLA (T-DM1) safety study.